Literature DB >> 3363537

Mild haemostatic problems associated with congenital heterozygous alpha 2-antiplasmin deficiency.

F W Leebeek1, J Stibbe, E A Knot, C Kluft, M J Gomes, M Beudeker.   

Abstract

A Dutch family, of which 13 members are heterozygotes, deficient for alpha 2-antiplasmin (alpha 2-AP) is reported. Clinical studies showed that 2 heterozygotes had a mild bleeding tendency, which presented as bleeding episodes after tooth extraction and after surgery and, in one patient, also as excessive menstruation. Laboratory investigations revealed an alpha 2-AP activity of 62% (51-71) (median and range) and an antigen level of 60% (60-66). The plasminogen binding as well as the fibrin binding properties of alpha 2-AP were normal. Plasminogen concentrations were significantly higher in the heterozygotes compared to the other family members. However, free plasminogen not bound to histidine-rich glycoprotein was not significantly different between these two groups. We propose that in this family the deficiency of alpha 2-AP is due to a decreased synthesis of a normal alpha 2-AP molecule. This present study brings the frequency of heterozygous alpha 2-AP deficient patients with a bleeding tendency to 13 out of 59 heterozygotes reported in the literature.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3363537

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

Review 1.  Clinical disorders of fibrinolysis: a critical review.

Authors:  R B Francis
Journal:  Blut       Date:  1989-07

2.  Fibrinolysis in patients with a mild-to-moderate bleeding tendency of unknown cause.

Authors:  Johanna Gebhart; Sylvia Kepa; Stefanie Hofer; Silvia Koder; Alexandra Kaider; Alisa S Wolberg; Helmuth Haslacher; Peter Quehenberger; Ernst Eigenbauer; Simon Panzer; Christine Mannhalter; Ingrid Pabinger
Journal:  Ann Hematol       Date:  2016-12-26       Impact factor: 3.673

3.  Thrombin-generating potential, plasma clot formation, and clot lysis are impaired in patients with bleeding of unknown cause.

Authors:  Stefanie Hofer; Cihan Ay; Judit Rejtö; Alisa S Wolberg; Helmuth Haslacher; Silvia Koder; Ingrid Pabinger; Johanna Gebhart
Journal:  J Thromb Haemost       Date:  2019-07-15       Impact factor: 5.824

4.  Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield.

Authors:  Lars L F G Valke; Danielle Meijer; Laurens Nieuwenhuizen; Britta A P Laros-van Gorkom; Nicole M A Blijlevens; Waander L van Heerde; Saskia E M Schols
Journal:  Res Pract Thromb Haemost       Date:  2022-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.